Company intelligence / Profile preview

Scion Life Sciences

New York City, New York, United States

Ownership: Private
Development stage: Other

Overview

Scion Life Sciences is a New York City-based venture capital firm focused on founding and building biotechnology companies that develop clinically transformational or curative medicines. The team provides long-term operational support and funding from pre-seed through IPO/commercialization. As of early 2025, their first wave of portfolio companies is launching but specific clinical results have not been disclosed publicly.

Therapeutic areas: Rare DiseasesOther
Modalities: Small moleculesBiologicsmRNA-based drugsAntibody therapiesAdvanced therapeutics
Industry: Investors

Partnerships

Petrichor

Beyond the preview

Go deeper on Scion Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scion Life Sciences.

Explore the full profile